Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

Novel immunologic classification of aspergillosis in adult cystic fibrosis

(2013) Caroline G. Baxter et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Diagnostic Performance of Various Tests and Criteria Employed in Allergic Bronchopulmonary Aspergillosis: A Latent Class Analysis

(2013) Ritesh Agarwal et al.   PLoS One

The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis

(2012) Richard B. Moss   Annals of the New York Academy of Sciences

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1

(2012) J. Agbetile et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis

(2012) C.G. Baxter et al.   CLINICAL MICROBIOLOGY AND INFECTION

Duration of Voriconazole Exposure: An Independent Risk Factor for Skin Cancer After Lung Transplantation

(2012) Fiona O. Zwald et al.   DERMATOLOGIC SURGERY

Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA: Figure 1–

(2012) Cendrine Godet et al.   EUROPEAN RESPIRATORY JOURNAL

Mannose-binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis

(2012) E. Harrison et al.   International Journal of Immunogenetics

Fungi and allergic lower respiratory tract diseases

(2012) Alan P. Knutsen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Voriconazole and Posaconazole Improve Asthma Severity in Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitization

(2012) Livingstone Chishimba et al.   JOURNAL OF ASTHMA

Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens

(2012) Yael Gernez et al.   Journal of Cystic Fibrosis

Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence

(2012) Catherine H. Pashley et al.   MEDICAL MYCOLOGY

Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults

(2012) David W. Denning et al.   MEDICAL MYCOLOGY

HLA-DRB1 and HLA-DQB1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

(2012) Manuel Muro et al.   MICROBIOLOGY AND IMMUNOLOGY

Allergic Bronchopulmonary Aspergillosis with Aspergilloma: An Immunologically Severe Disease with Poor Outcome

(2012) Ritesh Agarwal et al.   MYCOPATHOLOGIA

Pleural Effusion in a Patient With Allergic Bronchopulmonary Aspergillosis

(2012) K. Madan et al.   Respiratory Care

Serologic allergic bronchopulmonary aspergillosis (ABPA-S): Long-term outcomes

(2012) Ritesh Agarwal et al.   RESPIRATORY MEDICINE

Allergic bronchopulmonary aspergillosis in a patient with chronic obstructive pulmonary disease

(2012) Elias Mir et al.   Primary Care Respiratory Journal

Management of allergic bronchopulmonary aspergillosis: a review and update

(2012) Mahboobeh Mahdavinia et al.   Therapeutic Advances in Respiratory Disease

Long-term oxygen therapy

(2012) Surinder K Jindal et al.   Expert Review of Respiratory Medicine

What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization

(2012) Ritesh Agarwal   Expert Review of Respiratory Medicine

Allergic bronchopulmonary aspergillosis and omalizumab

(2011) I. Tillie-Leblond et al.   ALLERGY

Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma

(2011) D. Menzies et al.   ALLERGY

High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole

(2011) Pierre-Régis Burgel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease

(2011) David W. Denning et al.   CLINICAL INFECTIOUS DISEASES

Severe Asthma with Fungal Sensitization

(2011) Ritesh Agarwal   CURRENT ALLERGY AND ASTHMA REPORTS

Role of Inhaled Corticosteroids in the Management of Serological Allergic Bronchopulmonary Aspergillosis (ABPA)

(2011) Ritesh Agarwal et al.   INTERNAL MEDICINE

Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome

(2011) Jan Lötvall et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Link between CFTR mutations and ABPA: a systematic review and meta-analysis

(2011) Ritesh Agarwal et al.   MYCOSES

Clinical significance of Aspergillus sensitisation in bronchial asthma

(2011) Ritesh Agarwal et al.   MYCOSES

Lebrikizumab Treatment in Adults with Asthma

(2011) Jonathan Corren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations

(2011) D.J. Serisier et al.   RESPIRATORY MEDICINE

Allergic Bronchopulmonary Aspergillosis and Related Allergic Syndromes

(2011) Celia Hogan et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Effects of omalizumab in Aspergillus-associated airway disease

(2011) L. A. Perez-de-Llano et al.   THORAX

Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis

(2011) Ritesh Agarwal et al.   Journal of Infection and Public Health

IgE Sensitization toAspergillus fumigatusIs Associated with Reduced Lung Function in Asthma

(2010) Abbie Fairs et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Frequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis

(2010) Ashok Shah et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Efficacy and Safety of Posaconazole for Chronic Pulmonary Aspergillosis

(2010) Timothy W. Felton et al.   CLINICAL INFECTIOUS DISEASES

Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis

(2010) Richard B Moss   CURRENT OPINION IN PULMONARY MEDICINE

Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma

(2010) N. L. Smith et al.   EUROPEAN RESPIRATORY JOURNAL

Coevolution of TH1, TH2, and TH17 Responses during Repeated Pulmonary Exposure toAspergillus fumigatusConidia

(2010) Benjamin J. Murdock et al.   INFECTION AND IMMUNITY

Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands

(2010) C. H. W. Klaassen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Measured Immunoglobulin E in Allergic Bronchopulmonary Aspergillosis Treated With Omalizumab

(2010) Robert Y. Lin et al.   JOURNAL OF ASTHMA

Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis

(2010) James L. Kreindler et al.   JOURNAL OF CLINICAL INVESTIGATION

Tremor: a newly described adverse event with long-term itraconazole therapy

(2010) J. M Lestner et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Aspergillushypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA?

(2010) Ritesh Agarwal et al.   MEDICAL MYCOLOGY

Severe asthma and fungi: current evidence

(2010) Ritesh Agarwal et al.   MEDICAL MYCOLOGY

Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis

(2010) Don Hayes et al.   PEDIATRIC PULMONOLOGY

Bolus Methylprednisolone Efficacy for Uncontrolled Exacerbation of Cystic Fibrosis in Children

(2010) S. Ghdifan et al.   PEDIATRICS

Severe Asthma With Fungal Sensitization in a Child: Response to Itraconazole Therapy

(2010) A. G. Vicencio et al.   PEDIATRICS

CHIT1 Mutations: Genetic Risk Factor for Severe Asthma With Fungal Sensitization?

(2010) A. G. Vicencio et al.   PEDIATRICS

An Alternate Method of Classifying Allergic Bronchopulmonary Aspergillosis Based on High-Attenuation Mucus

(2010) Ritesh Agarwal et al.   PLoS One

Traitement de l’ABPA : une place pour le voriconazole et l’omalizumab ?

(2010) P. Mulliez   REVUE DES MALADIES RESPIRATOIRES

Effet rebond après utilisation du voriconazole dans le traitement de l’ABPA

(2010) P. Mulliez et al.   REVUE DES MALADIES RESPIRATOIRES

Molecular and immunological characterization of Asp f 34, a novel major cell wall allergen ofAspergillus fumigatus

(2009) A. G. Glaser et al.   ALLERGY

Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis

(2009) F. Brinkmann et al.   ALLERGY

A rare cause of miliary nodules — allergic bronchopulmonary aspergillosis

(2009) R AGARWAL et al.   BRITISH JOURNAL OF RADIOLOGY

Allergic Bronchopulmonary Aspergillosis

(2009) Ritesh Agarwal   CHEST

Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring

(2009) Jodi M. Lestner et al.   CLINICAL INFECTIOUS DISEASES

Innate Immunity to Aspergillus Species

(2009) S. J. Park et al.   CLINICAL MICROBIOLOGY REVIEWS

Total IgE levels and asthma prevalence in the US population: Results from the National Health and Nutrition Examination Survey 2005-2006

(2009) Peter J. Gergen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Resolution of Corticosteroid-Induced Diabetes in Allergic Bronchopulmonary Aspergillosis with Omalizumab Therapy: A Novel Approach

(2009) Inderpal Randhawa et al.   JOURNAL OF ASTHMA

Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis

(2009) Malena Cohen-Cymberknoh et al.   Journal of Cystic Fibrosis

Life-threatening allergic bronchopulomnary aspergillosis treated with methylprednisolone and anti-IgE monoclonal antibody

(2009) Matthew F Thomas   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Fungal rhinosinusitis

(2009) Arunaloke Chakrabarti et al.   LARYNGOSCOPE

A rare cause of acute respiratory failure - allergic bronchopulmonary aspergillosis

(2009) Ritesh Agarwal et al.   MYCOSES

Surface hydrophobin prevents immune recognition of airborne fungal spores

(2009) Vishukumar Aimanianda et al.   NATURE

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

(2009) Parameswaran Nair et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis

(2009) Ritesh Agarwal et al.   RESPIRATORY MEDICINE

The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis

(2009) Alessandro C. PASQUALOTTO et al.   RESPIROLOGY

Neuropathie périphérique sous voriconazole au cours d’une aspergillose pulmonaire cavitaire chronique

(2009) A. Gendrot et al.   REVUE DE MEDECINE INTERNE

Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization

(2008) David W. Denning et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?

(2008) Y. Laoudi et al.   EUROPEAN RESPIRATORY JOURNAL

Polymorphisms in Toll‐Like Receptor Genes and Susceptibility to Pulmonary Aspergillosis

(2008) A. Carvalho et al.   JOURNAL OF INFECTIOUS DISEASES

Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis

(2008) Jacquelyn M. Zirbes et al.   PEDIATRIC PULMONOLOGY

Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab)

(2008) Adaobi Kanu et al.   PEDIATRIC PULMONOLOGY